Basic Information | Post buying leads | Suppliers | Cas Database |
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate
voriconazole
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In dichloromethane for 0.5h; | 92% |
With sodium hydrogencarbonate In water; ethyl acetate | 90.47% |
With sodium hydroxide In water at 45 - 55℃; for 2.5h; Product distribution / selectivity; | 87.22% |
voriconazole
Conditions | Yield |
---|---|
With sodium hydroxide In dichloromethane; water pH=11 - 12; | 92% |
voriconazole
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In dichloromethane for 0.5h; | 92% |
With sodium hydroxide In dichloromethane; water at 15 - 25℃; pH=10 - 11; |
voriconazole
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In dichloromethane for 0.5h; | 90.8% |
With sodium hydroxide In dichloromethane; water pH=12.3; Product distribution / selectivity; Alkaline aqueous solution; Industry scale; | 72% |
With sodium hydroxide In dichloromethane; water pH=11; Product distribution / selectivity; Alkaline aqueous solution; |
voriconazole
Conditions | Yield |
---|---|
With 5%-palladium/activated carbon; hydrogen In ethanol under 760.051 Torr; | 86.3% |
(2R,3S)-3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1 yl)butan-2-ol
voriconazole
Conditions | Yield |
---|---|
With palladium 10% on activated carbon; potassium formate In ethanol; water at 30℃; for 1h; Temperature; Reagent/catalyst; Inert atmosphere; | 84.9% |
With palladium 10% on activated carbon; hydrogen; sodium acetate In water; toluene at -21 - 40℃; under 3750.38 Torr; for 22h; |
(2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt
voriconazole
Conditions | Yield |
---|---|
With sodium carbonate In dichloromethane; water at 20℃; for 0.333333h; pH=~ 10; Product distribution / selectivity; | 76% |
With sodium hydroxide In dichloromethane; water pH=11 - 12; Product distribution / selectivity; |
voriconazole
Conditions | Yield |
---|---|
With water In ethanol at 32.5℃; Concentration; Solvent; Temperature; | 76% |
voriconazole
Conditions | Yield |
---|---|
With [(1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid In methanol; acetone for 2h; Reflux; | 43% |
With (R)-10-camphorsulfonic acid In methanol; acetone at 0 - 5℃; Resolution of racemate; | 40.1% |
Multi-step reaction with 2 steps 1: acetone; methanol / 15 h / -20 - 25 °C 2: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14 View Scheme | |
Multi-step reaction with 2 steps 1: methanol; acetone / Reflux 2: sodium hydroxide / water; dichloromethane / pH 11 View Scheme |
5-fluoro-4-vinylpyrimidine
1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone
voriconazole
Conditions | Yield |
---|---|
With CuF(PPh3)3 methanol solvate; (R)-(−)-1-[(R)-2-(2′-diphenylphosphinophenyl)ferrocenyl]ethylbis(di-3,5-trifluoromethylphenyl)phosphine at 0℃; for 21.5h; Reagent/catalyst; Inert atmosphere; | 40% |
Molecular structure of Voriconazole (CAS NO.137234-62-9) is:
Product Name: Voriconazole
CAS Registry Number: 137234-62-9
IUPAC Name: (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
Molecular Weight: 349.31047 [g/mol]
Molecular Formula: C16H14F3N5O
XLogP3-AA: 1.5
H-Bond Donor: 1
H-Bond Acceptor: 8
Melting Point: 127-130 °C
Surface Tension: 45.1 dyne/cm
Density: 1.42 g/cm3
Flash Point: 261.4 °C
Enthalpy of Vaporization: 82.02 kJ/mol
Boiling Point: 508.6 °C at 760 mmHg
Vapour Pressure: 3.63E-11 mmHg at 25°C
Product Categories: API; Antifungal (Systemic); Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals
London, UK, 16 December 2008 - The effectiveness of voriconazole in combating fungal infections has been confirmed by a new study to be featured in the International Journal of Antimicrobial Agents ,published by Elsevier.
Voriconazole (CAS NO.137234-62-9) is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.
The most common side effects associated with voriconazole(137234-62-9) include transient visual disturbances, fever, rash, vomiting, nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain, and respiratory disorder.This medication may also cause the skin to peel easily. It is best to apply lotion and/or coconut oil to help with this side effect.
Safty information about Voriconazole (CAS NO.137234-62-9) is:
Hazard Codes: Xn
Risk Statements: 22-36/38
R22:Harmful if swallowed.
R36/38:Irritating to eyes and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
Voriconazole , its cas register number is 137234-62-9. It also can be called Voriconazole [USAN:INN:BAN] ; (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-,(alphaR,betaS)- ; DRG-0301 ; UK-109,496 ; UNII-JFU09I87TR ; VRC ; Vfend ; Voriconazole ; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))- . It is a cyrstalline solid.